Review
Copyright ©The Author(s) 2025.
World J Transplant. Jun 18, 2025; 15(2): 101005
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.101005
Table 1 Meta-analyses of atrial arrhythmias following lung transplantation
Ref.
Year
No. of studies
Total cases
AA
Conclusions

Saglietto et al[5]202172068This study looked only at late AA. Late atrial fibrillation rare–especially in double lung transplant (incidence rate only 0.9%/year)
Saad et al[7]201712320327%Early AA increases mortality and hospital stay. Predictors of early AA are elderly age, male sex, smoking, HT, hyperlipidaemia, CAD, increased LA diameter, and restrictive lung disease
Waldron et al[8]20179265329.8%AA was associated with higher mortality, longer hospital stays, increased need for tracheostomy
Fan et al[9]201611209431%Risk factors include elderly age, male, prior AA, cystic fibrosis, interstitial lung disease, CAD, HT, hyperlipidaemia, LA size. Increases mortality and hospital stay
Table 2 Incidence of post operative atrial fibrillation after different categories of surgery
Description
Incidence (%)
Transplant surgery
Lung transplantation[32,33]17 to 46
Heart transplantation[36,37]10 to 20
Thoracic surgery[38]
Overall cardiac surgeryApproximately 30
Coronary artery bypass surgeryApproximately 10 to 20
Thoracic (non-cardiac) surgery[38]
OverallApproximately 15
PneumonectomyApproximately 30
General (non-cardiothoracic) surgery[40]0.39
Table 3 Studies demonstrating increased mortality due to atrial arrhythmias after lung transplantation
Ref.
Year
Study type
Effect on mortality
Magnusson et al[53]2022Case seriesIncrease
Kim et al[44]2020Case seriesIncrease
Roukoz et al[6]2018ReviewMay be increased
Waldron et al[8]2017Meta-analysisIncrease
Saad et al[7]2017Meta-analysisIncrease
D'Angelo et al[54]2016Case seriesIncrease
Fan et al[9]2016Meta-analysisIncrease
Orrego et al[48]2014Case seriesIncrease
Henri et al[51]2012Case seriesIncrease
Isiadinso et al[35]2011Case seriesIncrease
Garcia et al[55]2011Case seriesIncrease
Table 4 Studies demonstrating no effect on mortality due to atrial arrhythmias after lung transplantation
Ref.
Year
Study type
Effect on mortality
Barnes et al[45]2020Case control studyNo effect
Campos Silva et al[46]2018Case seriesNo effect
Jesel et al[50]2017Case seriesNo effect
Raghavan et al[56]2015Case seriesNo effect
Chaikriangkrai et al[24]2015Case seriesNo effect
Mason et al[49]2007Case seriesNo effect
Table 5 Treatment strategy in various studies of atrial arrhythmias after lung transplantation, n (%)
Ref.
Year
Study type
Lung transplantation patients
Atrial fibrillation patients
Rate control
Rhythm control
Direct current cardioversion
Campos Silva et al[46]2018Case series7432 (43)67225
Waldron et al[8]2017Meta-analysis2653791 (30)624737
D'Angelo et al[54]2016Case series652198 (30)42633
Raghavan et al[56]2015Case series13146 (35)875335
Orrego et al[48]2014Case series36693 (25)402813
Henri et al[51]2012Case series22465 (29)404628
See et al[23]2009Case series12740 (32)561515
Mason et al[49]2007Case series33368 (20)27836
Table 6 Studies describing amiodarone use in atrial arrhythmias following lung transplantation, n (%)
Ref.
Year
Study type
Atrial fibrillation patients
Amiodarone use
Notes
Magnusson et al[53]2022Case series
15963 (40)Amiodarone increase mortality but not chronic lung allograft dysfunction
Hathaway et al[43]2021Case series
10277 (79)No difference between amiodarone and others. Safe to use
Kim et al[44]2020Case series 466 (13)No mention of any amiodarone related adverse effect
Barnes et al[45]2020Case control study10048 (alone), 26 (combination)Recommend amiodarone as the first drug to be used
Malik et al[34]2013Case series2724 (88.9)No mention of any amiodarone related adverse effect
Isiadinso et al[35]2011Case series6238 (65)24 out of 38 (64%) of patients treated with amiodarone died
Diaz-Guzman et al[81]2009Case report11 patientAmiodarone pulmonary toxicity–resolved with cessation and steroids
Table 7 Case series on catheter ablation for atrial arrhythmias following lung transplantation, n (%)
Ref.
Year
LT patients
AA patients, n (% of LT)
CA patients, n (% of AA)
Time to CA
Outcome
Mariani et al[106]20211575% free from recurrence at median of 19 months (6-86 months)
Hussein et al[28]201775532 (4.2)8 (25)43 months (20-54 months)At 3 years, 6 (75) stayed in SR. 2 patients had recurrence and 1 had re-do CA
Chaikriangkrai et al[24]2015293Early 48 (16.3), late 42 (14.3)25 (8.5)80% of late AA were from left atrium. 20% of late AA were from right atrial
Azadani et al[52]201126935 (13)3 (8.6)Patient (no. 1) = 1 year. Patient (no. 2) = 28 days. Patient (no. 3) = 18 monthsPatient (no. 1) = no recurrence at 1 months. Patient (no. 2) = no recurrence at 6 months. Patient (no. 3) = recurrence at 8 months and had second ablation
See et al[23]200912740 (31.5)4 (12)2 patients reverted to SR. 1 patient had 3 prior ablations. All 4 patients remained free of AA, 3 without anti arrhythmic drugs
Table 8 Case reports on catheter ablation for atrial arrhythmias following lung transplantation
Ref.
Year
Type of atrial arrhythmias
How long after lung transplantation
Site of foci
Type of catheter ablation
Outcome
Notes
Guan et al[109]2020AT10 yearsLeft PV-LA anastomosisRadiofrequencyAT terminatedNo recurrence in 3 months
Uhm et al[25]2018AT10 monthsPV anastomotic line–left sideRFCARevertedNo recurrence in 6 months. Electrical reconnection in all 4 PVs
Baykaner and Cooper[110]2018AFL7 yearsLeft PV siteRFCAReverted
Itoh and Yamada[111]2017AFL14 yearsPV-LA right
RFCARevertedElectrical reconnection noted
Sanam et al[27]2015AFL9 yearsDonor PVRFCAReverted
Nazmul et al[26]2011AT1 yearLeft upper PVRFCARevertedNo recurrence in 4 years
Nguyen and Marcus[107]2010AFL2 monthsPV-LARFCARevertedNo recurrence in 6 months
Sacher et al[108]2008AT10 monthsLARFCAReverted